NHS England reveals plan to improve cancer survival rates

NHS England has ordered an independent taskforce to develop a five-year action plan with the aim of improving cancer survival rates and services. The Commissioning Through Evaluation programme to innovative radiotherapy treatment and stereotactic abiative radiotherapy (SABR) will also be extended. This should enable the number of cancer patients eligible to access SABR treatment to rise by 750 new patients a year. The programme will widen the number of cancers being treated to include oligometastatic disease, primary liver tumours, spinal tumours, the re-irradiation of cancers in the pelvis and other selected indications.

PM LiveOnMedicaDaily Mail